Physician profile
Gregory Polly
NPI 1073828547
$3,569.26
in general payments reported to CMS, 2019-2025
40 companies · $1,426 in 2025
The $1,426 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $42.21 · 2022: $296 · 2023: $656 · 2024: $874 · 2025: $1,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,956.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $471.61 | 2020-2025 | |
| Abbvie INC. | $444.16 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $442.46 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $389.62 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $238.10 | 2019-2025 | Evenity, Prolia |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $209.68 | 2023-2025 | Caplyta |
| Abbott Laboratories | $128.33 | 2022-2025 | Freestyle Libre 3, Freestyle Libre |
| Lilly USA, LLC | $124.61 | 2019-2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $111.12 | 2019-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $91.53 | 2024-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $87.09 | 2019-2024 | |
| Exact Sciences Corporation | $87.05 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.36 | 2019-2024 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $58.00 | 2019-2023 | Shingrix |
| Tempus Ai, INC | $47.51 | 2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Polly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.